简介：
Overview
This article presents a protocol for generating patient-derived organoids (PDOs) from human primary bladder cancer. PDOs are valuable for studying the genetic and phenotypic diversity of cancer and for evaluating personalized treatment responses.
Key Study Components
Area of Science
- Translational cancer research
- Urological cancers
- Precision medicine
Background
- Patient-derived organoids mimic the heterogeneity of urological cancers.
- They can be rapidly expanded from limited biopsy material.
- PDOs serve as models for understanding cancer biology.
- They help predict treatment responses in individual patients.
Purpose of Study
- To provide a consolidated protocol for generating bladder cancer PDOs.
- To facilitate phenotypic analyses and drug response evaluations.
- To enhance understanding of the cellular and molecular basis of urological cancers.
Methods Used
- Collection of fresh tumor specimens from surgery.
- Transport of samples in sterile conditions.
- Replacement of transport medium with basal media.
- Allowing tumor tissue to settle for further processing.
Main Results
- Successful generation of PDOs that reflect patient tumor characteristics.
- PDOs can be used for drug response testing.
- Facilitates personalized treatment strategies.
- Enhances understanding of tumor biology.
Conclusions
- PDOs are a robust model for studying bladder cancer.
- They offer insights into treatment responses and cancer mechanisms.
- This protocol can be applied to other urological cancers.
What are patient-derived organoids?
Patient-derived organoids are 3D cell cultures derived from patient tumor samples that mimic the original tumor's characteristics.
How are organoids generated from tumor samples?
Organoids are generated by isolating tumor cells from biopsy material and culturing them in specific media.
What is the significance of using PDOs in cancer research?
PDOs allow researchers to study the heterogeneity of tumors and predict individual responses to therapies.
Can PDOs be used for drug testing?
Yes, PDOs can be used to evaluate the efficacy of various treatments on patient-specific cancer models.
What types of cancers can PDOs be derived from?
PDOs can be derived from various types of cancers, including bladder and other urological cancers.
How do PDOs contribute to precision medicine?
PDOs help tailor treatments based on the unique characteristics of a patient's tumor, improving treatment outcomes.
繁體中文
